Sun Pharmaceutical Industries Limited Financial Ratios
SUNPHARMA · Healthcare · Current price ₹1,758.8
P/E ratio
36.8x
P/B ratio
5.3x
ROE
13.7%
ROCE
17.5%
Debt / Equity
0.06
Dividend yield
0.9%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 36.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 5.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 13.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 17.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.06 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Sun Pharmaceutical Industries Limited's latest numbers.
Sun Pharmaceutical Industries Limited profitability
Sun Pharmaceutical Industries Limited generates a return on equity of 13.7% and a return on capital employed of 17.5%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.06 and a P/E of 36.8x, Sun Pharmaceutical Industries Limited is conservatively financed. Our overall business-quality score for the company is 5.2 / 10.
Understand the ratios
More on Sun Pharmaceutical Industries Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.